Dextromethorphan Hydrobromide And Guaifenesin Syrup
NDC Package 85722-0002-4
Package Information
Dextromethorphan Hydrobromide And Guaifenesin syrups is take evey 4 hoursdo not take more than 6 doses in any 24-hour periodmeasure only with dosing cup providedkeep dosing cup with productAgeDoseAdults and children 12 years and over5 mL every 4 hoursChildren under 12 yearsdo not use. This formulation utilizes a syrup delivery system. Marketed by Kjd Pharma Private Limited, this product is identified by NDC 85722-0002 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1117394 - dextromethorphan HBr 20 MG / guaiFENesin 300 MG in 5 mL Oral Solution
- RxCUI: 1117394 - dextromethorphan hydrobromide 4 MG/ML / guaifenesin 60 MG/ML Oral Solution
- RxCUI: 1117394 - dextromethorphan hydrobromide 20 MG / guaifenesin 300 MG per 5 ML Oral Solution
Clinical Specifications
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 85722 - Kjd Pharma Private Limited
- 85722-0002 - Dextromethorphan Hydrobromide And Guaifenesin
- 85722-0002-4 - 118 mL in 1 BOTTLE
- 85722-0002 - Dextromethorphan Hydrobromide And Guaifenesin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (85722-0002). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85722-0002-4 identifies a specific commercial package of 118 ml in 1 bottle of Dextromethorphan Hydrobromide And Guaifenesin, a human over the counter drug labeled by Kjd Pharma Private Limited. This syrup is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kjd Pharma Private Limited on February 01, 2021. The current certification is valid through December 31, 2026.
How is this Kjd Pharma Private Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85722000204. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.